News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
836,830 Results
Type
Article (85968)
Company Profile (649)
Press Release (750213)
Section
Business (232160)
Career Advice (4124)
Deals (39703)
Drug Delivery (125)
Drug Development (90767)
Employer Resources (198)
FDA (17971)
Job Trends (17309)
News (395438)
Policy (39640)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2984)
Academic (1)
Accelerated approval (3)
Adcomms (25)
Allergies (75)
Alliances (56606)
ALS (72)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (126)
Approvals (17964)
Artificial intelligence (204)
Autoimmune disease (18)
Automation (10)
Bankruptcy (401)
Best Places to Work (12519)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (447)
Bladder cancer (57)
Brain cancer (25)
Breast cancer (204)
Cancer (1783)
Cardiovascular disease (125)
Career advice (3527)
Career pathing (33)
CAR-T (149)
Cell therapy (418)
Cervical cancer (16)
Clinical research (72550)
Collaboration (712)
Compensation (376)
Complete response letters (27)
COVID-19 (2822)
CRISPR (40)
C-suite (189)
Cystic fibrosis (97)
Data (1645)
Decentralized trials (2)
Denatured (43)
Depression (34)
Diabetes (170)
Diagnostics (6734)
Digital health (8)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (106)
Drug pricing (93)
Drug shortages (17)
Duchenne muscular dystrophy (74)
Earnings (95046)
Editorial (34)
Employer branding (25)
Employer resources (167)
Events (127895)
Executive appointments (537)
FDA (18824)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (590)
Gene editing (92)
Generative AI (21)
Gene therapy (291)
GLP-1 (714)
Government (5074)
Grass and pollen (3)
Guidances (33)
Healthcare (20736)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (115)
Indications (22)
Infectious disease (2925)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (39)
Intellectual property (77)
Interviews (812)
IPO (17674)
IRA (39)
Job creations (5183)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (522)
Leadership (19)
Legal (10049)
Liver cancer (69)
Lung cancer (264)
Lymphoma (114)
Machine learning (2)
Management (65)
Manufacturing (255)
MASH (61)
Medical device (14286)
Medtech (14291)
Mergers & acquisitions (22233)
Metabolic disorders (553)
Multiple sclerosis (66)
NASH (22)
Neurodegenerative disease (87)
Neuropsychiatric disorders (23)
Neuroscience (1877)
NextGen: Class of 2025 (7666)
Non-profit (5054)
Northern California (2114)
Now hiring (38)
Obesity (301)
Opinion (267)
Ovarian cancer (67)
Pain (60)
Pancreatic cancer (58)
Parkinson's disease (117)
Partnered (16)
Patents (172)
Patient recruitment (81)
Peanut (48)
People (64693)
Pharmaceutical (131)
Pharmacy benefit managers (14)
Phase I (22403)
Phase II (31544)
Phase III (23724)
Pipeline (857)
Podcasts (121)
Policy (110)
Postmarket research (3542)
Preclinical (10068)
Press Release (72)
Prostate cancer (76)
Psychedelics (34)
Radiopharmaceuticals (249)
Rare diseases (339)
Real estate (7379)
Recruiting (75)
Regulatory (26312)
Reports (55)
Research institute (2643)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (2)
RSV (30)
Schizophrenia (64)
Series A (117)
Series B (68)
Service/supplier (25)
Sickle cell disease (45)
Southern California (1803)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4281)
State (2)
Stomach cancer (11)
Supply chain (45)
The Weekly (75)
United States (18310)
Vaccines (704)
Venture capitalists (36)
Webinars (13)
Weight loss (221)
Women's health (35)
Worklife (18)
Date
Today (14)
Last 7 days (484)
Last 30 days (2034)
Last 365 days (30441)
2025 (6429)
2024 (34079)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Alabama (50)
Alaska (6)
Arizona (239)
Arkansas (8)
Asia (49717)
Australia (8779)
California (4809)
Canada (1473)
China (445)
Colorado (155)
Connecticut (202)
Delaware (112)
Europe (113742)
Florida (593)
Georgia (134)
Hawaii (1)
Idaho (64)
Illinois (424)
India (23)
Indiana (256)
Iowa (9)
Japan (117)
Kansas (107)
Kentucky (16)
Louisiana (7)
Maine (58)
Maryland (794)
Massachusetts (3808)
Michigan (176)
Minnesota (300)
Mississippi (1)
Missouri (50)
Montana (24)
Nebraska (26)
Nevada (50)
New Hampshire (50)
New Jersey (1388)
New Mexico (27)
New York (1366)
North Carolina (957)
North Dakota (7)
Northern California (2114)
Ohio (155)
Oklahoma (13)
Oregon (44)
Pennsylvania (1028)
Puerto Rico (9)
Rhode Island (21)
South America (1647)
South Carolina (4)
South Dakota (1)
Southern California (1803)
Tennessee (30)
Texas (635)
Utah (108)
Virginia (91)
Washington D.C. (36)
Washington State (477)
West Virginia (1)
Wisconsin (35)
836,830 Results for "landmark bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ChromaTan and Landmark Bio Awarded National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Grant to Advance Intensified Recombinant Adeno-Associated Virus (AAV) Production Process
March 18, 2025
·
4 min read
Press Releases
LIfT BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the World Leader in Neutrophil Immunotherapies
March 13, 2025
·
3 min read
Press Releases
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology
October 16, 2024
·
6 min read
Press Releases
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
February 6, 2025
·
6 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
January 30, 2025
·
5 min read
Press Releases
Caris Life Sciences Publishes Landmark Study Demonstrating the Superiority of Caris Assure™
February 12, 2025
·
5 min read
Press Releases
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
March 28, 2025
·
3 min read
Press Releases
Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study
March 4, 2025
·
2 min read
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study
Crossject provides additional, clinically meaningful perspectives on ZEPIZURE® in light of its recently published bioequivalence study results and of the conclusions and hints by the authors of the RAMPART study1, a landmark double-blind randomized clinical trial comparing the efficacy of IM midazolam vs. IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics.
June 26, 2024
·
5 min read
1 of 83,683
Next
